BIOMAT Database Logo BIOMAT Database Logo

Growth suppression of esophageal cancer cells by p16INK4 and p15INK4B in vitro. 1996

X Zhou, and H Suzuki, and J Lei, and K Cole, and J Yin, and V Suzuki, and J M Abraham, and Y Shimada, and M Imamura, and T Chan, and G J Hannon, and S J Meltzer
Department of Medicine/GI Division, University of Maryland School of Medicine and Veterans Affairs Hospital, Baltimore, Maryland 21201, USA.

OBJECTIVE We investigate whether p16INK4 and p15INK4B inhibit cellular proliferation and exert a growth suppressive effect on esophageal cancer cells. METHODS The growth suppressive effects of p16INK4 and p15INK4B were evaluated by transfecting vectors containing the p16INK4 cDNA or the p15INK4B cDNA, or both, constitutively driven by a cytomegalovirus promoter, into two human esophageal cancer cell lines containing or lacking endogenous p16INK4 and/or p15INK4B. RESULTS These experiments demonstrated that in both cells lines tested, the numbers of cells surviving dramatically decreased in p16INK4-transfected and p15INK4B-transfected cells compared with control vector-transfected cells. There was no significant difference in the degree of growth inhibition between p16INK4-transfected and pI5INK4B-transfected cell lines. CONCLUSIONS These results suggest that p16INK4 and p15INK4B play important roles in the initiation or promotion of esophageal cancer. The inactivation of p16INK4 and p15INK4B may contribute to uncontrolled growth in human cancer.

UI MeSH Term Description Entries
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D050762 Cyclin-Dependent Kinase Inhibitor p15 An INK4 cyclin-dependent kinase inhibitor containing four ANKYRIN-LIKE REPEATS. INK4B is often inactivated by deletions, mutations, or hypermethylation in HEMATOLOGIC NEOPLASMS. CDKN2B Protein,Cyclin-Dependent Kinase Inhibitor 2B,INK4B Protein,INK4b Cyclin-Dependent Kinase Inhibitor,p15 CDK4 Inhibitor,p15INK4B Protein,CDK4 Inhibitor, p15,Cyclin Dependent Kinase Inhibitor 2B,Cyclin Dependent Kinase Inhibitor p15,INK4b Cyclin Dependent Kinase Inhibitor
D019941 Cyclin-Dependent Kinase Inhibitor p16 A product of the p16 tumor suppressor gene (GENES, P16). It is also called INK4 or INK4A because it is the prototype member of the INK4 CYCLIN-DEPENDENT KINASE INHIBITORS. This protein is produced from the alpha mRNA transcript of the p16 gene. The other gene product, produced from the alternatively spliced beta transcript, is TUMOR SUPPRESSOR PROTEIN P14ARF. Both p16 gene products have tumor suppressor functions. CDKN2 Protein,CDKN2A Protein,Cdk4-Associated Protein p16,Cyclin-Dependent Kinase Inhibitor-2A,INK4A Protein,MTS1 Protein,Multiple Tumor Suppressor-1,p16(INK4A),p16INK4 Protein,p16INK4A Protein,Cdk4 Associated Protein p16,Cyclin Dependent Kinase Inhibitor 2A,Cyclin Dependent Kinase Inhibitor p16,Multiple Tumor Suppressor 1,Protein, INK4A
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

X Zhou, and H Suzuki, and J Lei, and K Cole, and J Yin, and V Suzuki, and J M Abraham, and Y Shimada, and M Imamura, and T Chan, and G J Hannon, and S J Meltzer
[Analysis of the p16INK4, p15INK4B genes abnormality and the amplification of cyclin D1 gene in esophageal cancer].
April 1996, Nihon rinsho. Japanese journal of clinical medicine,
X Zhou, and H Suzuki, and J Lei, and K Cole, and J Yin, and V Suzuki, and J M Abraham, and Y Shimada, and M Imamura, and T Chan, and G J Hannon, and S J Meltzer
p16INK4 and p15INK4B alterations in primary gynecologic malignancy.
May 1997, Gynecologic oncology,
X Zhou, and H Suzuki, and J Lei, and K Cole, and J Yin, and V Suzuki, and J M Abraham, and Y Shimada, and M Imamura, and T Chan, and G J Hannon, and S J Meltzer
Growth suppression by p16ink4 requires functional retinoblastoma protein.
July 1995, Proceedings of the National Academy of Sciences of the United States of America,
X Zhou, and H Suzuki, and J Lei, and K Cole, and J Yin, and V Suzuki, and J M Abraham, and Y Shimada, and M Imamura, and T Chan, and G J Hannon, and S J Meltzer
p15ink4B and p16ink4 gene inactivation in acute lymphocytic leukemia.
June 1995, Blood,
X Zhou, and H Suzuki, and J Lei, and K Cole, and J Yin, and V Suzuki, and J M Abraham, and Y Shimada, and M Imamura, and T Chan, and G J Hannon, and S J Meltzer
Inactivation of the p15INK4B and p16INK4 genes in hematologic malignancies.
October 1996, Leukemia & lymphoma,
X Zhou, and H Suzuki, and J Lei, and K Cole, and J Yin, and V Suzuki, and J M Abraham, and Y Shimada, and M Imamura, and T Chan, and G J Hannon, and S J Meltzer
Suppression of growth in vitro and tumorigenicity in vivo of human carcinoma cell lines by transfected p16INK4.
May 1996, Molecular carcinogenesis,
X Zhou, and H Suzuki, and J Lei, and K Cole, and J Yin, and V Suzuki, and J M Abraham, and Y Shimada, and M Imamura, and T Chan, and G J Hannon, and S J Meltzer
Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.
July 1995, Cancer research,
X Zhou, and H Suzuki, and J Lei, and K Cole, and J Yin, and V Suzuki, and J M Abraham, and Y Shimada, and M Imamura, and T Chan, and G J Hannon, and S J Meltzer
Expression of the cyclin-dependent kinase inhibitors p16INK4, p15INK4B and p21WAF1/CIP1 in human breast cancer.
November 1995, International journal of cancer,
X Zhou, and H Suzuki, and J Lei, and K Cole, and J Yin, and V Suzuki, and J M Abraham, and Y Shimada, and M Imamura, and T Chan, and G J Hannon, and S J Meltzer
Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer.
April 1995, Cancer research,
X Zhou, and H Suzuki, and J Lei, and K Cole, and J Yin, and V Suzuki, and J M Abraham, and Y Shimada, and M Imamura, and T Chan, and G J Hannon, and S J Meltzer
Inhibition of esophageal cancer proliferation by adenovirally mediated delivery of p16INK4.
January 1996, Cancer gene therapy,
Copied contents to your clipboard!